PTC Therapeutics Inc.(PTCT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PTCT PTC Therapeutics Inc.

盘后交易 09-26 19:03:46 EDT

37.66

+1.02

+2.78%

盘后37.50

-0.16-0.42%

16:10 EDT

最高38.62	最低36.45	成交量116.16万
今开36.84	昨收36.64	日振幅5.92%
总市值28.97亿	流通市值22.89亿	总股本7,692万
成交额4,403万	换手率1.91%	流通股本6,078万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PTCT","market":"US","secType":"STK","nameCN":"PTC Therapeutics Inc.","latestPrice":37.66,"timestamp":1727380800000,"preClose":36.64,"halted":0,"volume":1161631,"hourTrading":{"tag":"盘后","latestPrice":37.5,"preClose":37.66,"latestTime":"16:10 EDT","volume":17150,"amount":645844.99,"timestamp":1727381454601},"delay":0,"floatShares":60782748,"shares":76924170,"eps":-6.307162,"marketStatus":"盘后交易","marketStatusCode":4,"change":1.02,"latestTime":"09-26 19:03:46 EDT","open":36.84,"high":38.62,"low":36.45,"amount":44027046.22886,"amplitude":0.059225,"askPrice":39.19,"askSize":10,"bidPrice":36,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-6.307162,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1727395200000},"adr":0,"listingDate":1371700800000,"adjPreClose":36.64,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":36.84,"preClose":36.64,"latestTime":"09:29 EDT","volume":130,"amount":4809.790180000001,"timestamp":1727357399999},"postHourTrading":{"tag":"盘后","latestPrice":37.5,"preClose":37.66,"latestTime":"16:10 EDT","volume":17150,"amount":645844.99,"timestamp":1727381454601},"volumeRatio":1.830734,"impliedVol":0.5645,"impliedVolPercentile":0.246},"requestUrl":"/m/hq/s/PTCT","defaultTab":"news","newsList":[{"id":"2470578937","title":"Ptc Therapeutics, Inc.盘中异动 股价大涨5.13%报38.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470578937","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470578937?lang=zh_cn&edition=full","pubTime":"2024-09-27 00:46","pubTimestamp":1727369185,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日00时46分，Ptc Therapeutics, Inc.股票出现波动，股价快速拉升5.13%。Ptc Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Pasithea Therapeutics Corp.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Pasithea Therapeutics Corp.、Nucana Plc、Kintara Therapeutics, Inc.较为活跃，换手率分别为4652.96%、165.43%、110.52%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Pasithea Therapeutics Corp.，振幅分别为72.58%、42.53%、42.13%。Ptc Therapeutics, Inc.公司简介：PTC Therapeutics Inc 是一家生物制药公司，专注于口服小分子疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927004625a1dcc7ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927004625a1dcc7ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","BK4139","LU0889565916.HKD","LENZ","PTCT","LU0109394709.USD"],"gpt_icon":0},{"id":"2460350244","title":"Ptc Therapeutics, Inc.2024财年第二财季实现净利润-99.18百万美元，同比增加50.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460350244","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460350244?lang=zh_cn&edition=full","pubTime":"2024-08-17 00:00","pubTimestamp":1723824035,"startTime":"0","endTime":"0","summary":"8月17日，Ptc Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-99.18百万美元，同比增加50.16%；其中营业收入为1.87亿美元，同比减少12.62%，每股基本收益为-1.29美元。从资产负债表来看，Ptc Therapeutics, Inc.总负债28.97亿美元，其中短期债务16.01百万美元，资产负债比为0.67，流动比率为2.23。机构评级：截至2024年8月17日，当前有12家机构对Ptc Therapeutics, Inc.目标价做出预测，其中目标均价为38.75美元，其中最低目标价为26.00美元，最高目标价为64.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170005539f31b105&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408170005539f31b105&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PTCT","LENZ"],"gpt_icon":0},{"id":"2458595146","title":"Ptc Therapeutics, Inc.盘中异动 股价大跌5.73%报30.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458595146","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458595146?lang=zh_cn&edition=full","pubTime":"2024-08-09 21:31","pubTimestamp":1723210269,"startTime":"0","endTime":"0","summary":"北京时间2024年08月09日21时31分，Ptc Therapeutics, Inc.股票出现波动，股价大幅跳水5.73%。Ptc Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Third Harmonic Bio, Inc.、Adma Biologics Inc涨幅较大，Conduit Pharmaceuticals Inc.、Cns Pharmaceuticals, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为32.28%、5.26%、4.90%，振幅较大的相关个股有Brainstorm Cell Therapeutics Inc.、Enliven Therapeutics, Inc.、Relmada Therapeutics, Inc.，振幅分别为10.21%、9.58%、9.57%。Ptc Therapeutics, Inc.公司简介：PTC Therapeutics Inc 是一家生物制药公司，专注于口服小分子疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809213109958bfd6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240809213109958bfd6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PTCT","LU0320765992.SGD","LENZ","LU0109394709.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2457775287","title":"Ptc Therapeutics, Inc.盘中异动 早盘快速跳水5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457775287","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457775287?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:40","pubTimestamp":1722865259,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时40分，Ptc Therapeutics, Inc.股票出现波动，股价大幅下挫5.37%。Ptc Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.18%。其相关个股中，Zevra Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Cervomed Inc.涨幅较大，Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃，换手率分别为1093.28%、54.23%、14.18%，振幅较大的相关个股有Cns Pharmaceuticals, Inc.、Alterity Therapeutics Limited、60 Degrees Pharmaceuticals, Inc.，振幅分别为21.59%、20.00%、17.81%。Ptc Therapeutics, Inc.公司简介：PTC Therapeutics Inc 是一家生物制药公司，专注于口服小分子疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805214059941fe364&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805214059941fe364&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD","BK4139","LENZ","PTCT"],"gpt_icon":0},{"id":"2452439114","title":"Ptc Therapeutics, Inc.盘中异动 股价大跌5.12%报32.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452439114","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452439114?lang=zh_cn&edition=full","pubTime":"2024-07-19 00:02","pubTimestamp":1721318553,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日00时02分，Ptc Therapeutics, Inc.股票出现波动，股价大幅跳水5.12%。Ptc Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.30%。其相关个股中，Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Onconetix, Inc.、Silo Pharma, Inc.涨幅较大，Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为2267.53%、2161.83%、1187.04%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。Ptc Therapeutics, Inc.公司简介：PTC Therapeutics Inc 是一家生物制药公司，专注于口服小分子疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407190002349681e1e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407190002349681e1e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","BK4139","LU0889565916.HKD","LENZ","PTCT","LU0109394709.USD"],"gpt_icon":0},{"id":"2451899229","title":"坎托菲茨杰拉德公司：重申PTC Therapeutics(PTCT.US)评级，由增持调整至增持评级, 目标价由62.00美元调整至62.","url":"https://stock-news.laohu8.com/highlight/detail?id=2451899229","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2451899229?lang=zh_cn&edition=full","pubTime":"2024-07-16 21:12","pubTimestamp":1721135528,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4576","LU0889565916.HKD","BK4588","LU1951198990.SGD","BK4585","BK4023","LU2506952410.USD","LU0320765992.SGD","LU2477742899.HKD","BK4554","BK4139","LU1951200564.SGD","LU1721428347.USD","LENZ","LU2506952337.HKD","PTCT","LU0109394709.USD","LU1923623000.USD","PTC"],"gpt_icon":0},{"id":"2448990541","title":"坎托菲茨杰拉德公司：维持PTC Therapeutics(PTCT.US)评级，由增持调整至增持评级, 目标价由52.00美元调整至62.","url":"https://stock-news.laohu8.com/highlight/detail?id=2448990541","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448990541?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:03","pubTimestamp":1719838999,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4554","BK4585","PTCT","BK4576","LU0320765992.SGD","BK4139","BK4588","LU0889565916.HKD","LU1951200564.SGD","LENZ","BK4023","LU1923623000.USD","LU0109394709.USD","PTC","LU1951198990.SGD"],"gpt_icon":0},{"id":"2448952768","title":"美国研究综述-AT&T, ATI, 加利福尼亚资源公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2448952768","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448952768?lang=zh_cn&edition=full","pubTime":"2024-07-01 15:23","pubTimestamp":1719818605,"startTime":"0","endTime":"0","summary":"    路透7月1日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括 AT&T、ATI 和加州资源公司。要闻  * AT&T Inc   ：摩根大通将其股票列入美国分析师关注名单  * ATI Inc   ：摩根大通将其股票从美国分析师关注名单中删除  * 加州资源公司   ：Gerdes Energy Research将其评级从 \"买入 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FCNCA","BK4207","LU0321505439.SGD","SPB","LU2065732104.USD","RIVN","ILMN","KNTK","ACCD","EQT","IE00B19Z3581.USD","BK4588","BK4505","LU0109394709.USD","BK4589","ATI","LU0889565916.HKD","BK4187","BK4213","IE00B7SZLL34.SGD","LU1621767810.EUR","LU1621767737.EUR","RCKT","ELAN","CENT","BK4018","INSM","PTCT","BK4507","SM","NOG","BK4144","CHRS","IE00BSNM7G36.USD","OVV","BK4585","BK4139","BK4562","BK4211","HXL","NKLA","LU0053671581.USD","CRC","BK4561","LU1621768115.EUR","APLS","TSHA","WBA","T","BK4196"],"gpt_icon":0},{"id":"2446880056","title":"Ptc Therapeutics, Inc.股价重挫15.20% 市值跌3.43亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446880056","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446880056?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:31","pubTimestamp":1719581505,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时31分，Ptc Therapeutics, Inc.股票出现波动，股价快速下跌15.20%。Ptc Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Revolution Medicines Inc C/Wts 17/12/2026 、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，Clearmind Medicine Inc.、Carisma Therapeutics, Inc.、Geovax Labs, Inc.较为活跃，换手率分别为191.61%、17.54%、15.43%，振幅较大的相关个股有Clearmind Medicine Inc.、Carisma Therapeutics, Inc.、Nanobiotix，振幅分别为13.43%、10.16%、8.84%。Ptc Therapeutics, Inc.公司简介：PTC Therapeutics Inc 是一家生物制药公司，专注于口服小分子疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406282131459f7138f5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202406282131459f7138f5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","LU0109394709.USD","PTCT","LU0320765992.SGD","LU0889565916.HKD","BK4139"],"gpt_icon":0},{"id":"2445075098","title":"Ptc Therapeutics, Inc.盘中异动 股价大涨5.11%报34.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445075098","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445075098?lang=zh_cn&edition=full","pubTime":"2024-06-21 21:35","pubTimestamp":1718976906,"startTime":"0","endTime":"0","summary":"北京时间2024年06月21日21时35分，Ptc Therapeutics, Inc.股票出现波动，股价急速拉升5.11%。Ptc Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Ptc Therapeutics, Inc.公司简介：PTC Therapeutics Inc 是一家生物制药公司，专注于口服小分子疗法的发现、开发和商业化。消息层面，截至21时35分，《摩根大通维持PTC Therapeutics买入评级，上调目标价至53美元》资讯为影响Ptc Therapeutics, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621213506941f01f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621213506941f01f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0889565916.HKD","BK4139","LENZ","LU0109394709.USD","PTCT"],"gpt_icon":0},{"id":"2445730103","title":"B of A Securities：维持PTC Therapeutics(PTCT.US)评级，由低于大市调整至低于大市评级, 目标价由25.","url":"https://stock-news.laohu8.com/highlight/detail?id=2445730103","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445730103?lang=zh_cn&edition=full","pubTime":"2024-06-21 18:40","pubTimestamp":1718966430,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4554","LU0320765992.SGD","BK4588","LU0109394709.USD","LU0889565916.HKD","PTCT","BK4585","PTC","BK4023","LENZ","BK4576","LU1951200564.SGD","BK4139","LU1951198990.SGD","LU1923623000.USD"],"gpt_icon":0},{"id":"2445176247","title":"小摩：维持PTC Therapeutics(PTCT.US)评级，由增持调整至增持评级, 目标价由53.00美元调整至53.","url":"https://stock-news.laohu8.com/highlight/detail?id=2445176247","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2445176247?lang=zh_cn&edition=full","pubTime":"2024-06-21 01:39","pubTimestamp":1718905191,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4576","IE00B775SV38.USD","LU2552382058.USD","LU0211328371.USD","LU0882574139.USD","LU0496365809.HKD","LU1244550221.USD","LU1951198990.SGD","IE00BZ1G4Q59.USD","LU0208291251.USD","LU0211326755.USD","LU0170899867.USD","BK4504","BK4585","LU0149725797.USD","LU0417517546.SGD","LU0234572021.USD","IE0034235188.USD","LU0320765992.SGD","LU1668664300.SGD","LU2023250504.SGD","LU1363072403.SGD","LU2552382132.HKD","IE00B1BXHZ80.USD","IE00BKVL7J92.USD","LU1496350171.SGD","LU2106854487.HKD","LU0211326839.USD","IE00BLSP4452.SGD","IE00BLSP4239.USD","LU1261432733.SGD","LU0106831901.USD","LU1951200564.SGD","LU2552382215.SGD","BK4207","LENZ","BK4550","LU1267930490.SGD","BK4566","LU0310799852.SGD","LU1917777945.USD","IE00BBT3K403.USD","LU0320765489.SGD","LU0109394709.USD","LU1670628061.USD","PTCT","LU1244550577.SGD","LU1923623000.USD","LU0971096721.USD","PTC"],"gpt_icon":0},{"id":"2444248544","title":"Ptc Therapeutics, Inc.盘中异动 急速下跌5.24%报33.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2444248544","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444248544?lang=zh_cn&edition=full","pubTime":"2024-06-20 22:25","pubTimestamp":1718893542,"startTime":"0","endTime":"0","summary":"北京时间2024年06月20日22时25分，Ptc Therapeutics, Inc.股票出现异动，股价大幅下挫5.24%。Ptc Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Clearmind Medicine Inc.、Geovax Labs, Inc.、Trevena, Inc.较为活跃，换手率分别为390.62%、196.34%、161.73%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Seastar Medical Holding Corp C/Wts 28/10/2027 、Trevena, Inc.，振幅分别为65244.36%、53.43%、45.71%。Ptc Therapeutics, Inc.公司简介：PTC Therapeutics Inc 是一家生物制药公司，专注于口服小分子疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062022254296815831&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024062022254296815831&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0889565916.HKD","BK4139","LENZ","LU0109394709.USD","PTCT"],"gpt_icon":0},{"id":"2442552219","title":"Ptc Therapeutics, Inc.盘中异动 股价大涨6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2442552219","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2442552219?lang=zh_cn&edition=full","pubTime":"2024-06-12 21:30","pubTimestamp":1718199046,"startTime":"0","endTime":"0","summary":"北京时间2024年06月12日21时30分，Ptc Therapeutics, Inc.股票出现波动，股价大幅上涨6.00%。Ptc Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Avidity Biosciences, Inc.、Molecular Partners Ag、阿诺医药涨幅较大，Tonix Pharmaceuticals Holding Corp.、Tracon Pharmaceuticals, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为34.87%、18.55%、3.16%，振幅较大的相关个股有Enliven Therapeutics, Inc.、Viracta Therapeutics, Inc.、Kodiak Sciences Inc，振幅分别为5.00%、4.85%、4.79%。Ptc Therapeutics, Inc.公司简介：PTC Therapeutics Inc 是一家生物制药公司，专注于口服小分子疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213046aef496fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240612213046aef496fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0889565916.HKD","LU0109394709.USD","PTCT","BK4139","LENZ"],"gpt_icon":0},{"id":"2437446288","title":"高盛：维持PTC Therapeutics(PTCT.US)评级，由卖出调整至卖出评级, 目标价由18.00美元调整至32.","url":"https://stock-news.laohu8.com/highlight/detail?id=2437446288","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437446288?lang=zh_cn&edition=full","pubTime":"2024-05-21 22:15","pubTimestamp":1716300935,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4023","BK4552","BK4588","LU0889565916.HKD","LENZ","LU0109394709.USD","LU1951200564.SGD","BK4504","PTC","BK4127","BK4554","BK4533","IE0034235188.USD","BK4550","LU1923623000.USD","LU1951198990.SGD","PTCT","LU0106831901.USD","BK4139","LU1668664300.SGD","IE00BSNM7G36.USD","BK4576","BK4585","LU0320765992.SGD"],"gpt_icon":0},{"id":"2437461766","title":"美国研究综述-Chemed、PTC Therapeutics、Regeneron Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2437461766","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437461766?lang=zh_cn&edition=full","pubTime":"2024-05-21 14:45","pubTimestamp":1716273908,"startTime":"0","endTime":"0","summary":"    路透5月21日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Chemed、PTC Therapeutics 和 Regeneron Pharmaceuticals。* Regeneron Pharmaceuticals Inc   ：杰富瑞将预测价格从1125美元上调至1135美元              * United Therapeutics Corp   ：摩根大通将目标价从280美元上调至300美元  以下是路透周二报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00BMPRXR70.SGD","TDOC","BK4532","LU1169589451.USD","LU1244550577.SGD","LU0256863811.USD","IE00BWXC8680.SGD","INSG","IE00B1BXHZ80.USD","LU2286300806.USD","PTCT","REGN","IE00BLSP4239.USD","LU0868494617.USD","DOMO","DECK","BOOT","LU0320765992.SGD","ALTG","BK4086","BK4167","NCLH","IE00B1XK9C88.USD","BK4146","BK4550","BK4142","LU0058720904.USD","OC","LU0211326839.USD","SJM","IE00B3S45H60.SGD","PTC","BK4576","ULS","SPIR","APA","PANW","IE00BBT3K403.USD","LU0289739699.SGD","LENZ","DXC","LU0211327993.USD","IE00B19Z9505.USD","BK4104","CHE","UTHR","FLO","DK","BK4548"],"gpt_icon":0},{"id":"2437483210","title":"BUZZ-欧洲监管机构将重新评估对肌肉失调药物的意见，PTC Therapeutics 上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2437483210","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437483210?lang=zh_cn&edition=full","pubTime":"2024-05-21 01:47","pubTimestamp":1716227279,"startTime":"0","endTime":"0","summary":"    5月20日 - ** 制药商PTC Therapeutics   股价上涨20.4%至39.86美元** 该公司称，欧盟执委会 已决定不采纳欧洲卫生监管机构顾问小组对该公司肌肉失调药物 Translarna 的负面意见。** 称欧盟执委会已将该意见退回卫生监管机构的顾问小组重新评估** 因此，Translarna仍可供欧洲患者使用 - PTCT** 欧盟执委会已要求顾问小组 \"在修订意见中进一步考虑全部证据，包括来自患者登记处的数据和真实世界的证据\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4554","BK4588","LU1951200564.SGD","BK4023","BUZZ","BK4576","LENZ","LU0109394709.USD","LU1923623000.USD","LU1951198990.SGD","PTC","PTCT","LU0320765992.SGD","LU0889565916.HKD","BK4139","BK4585"],"gpt_icon":0},{"id":"2437348300","title":"杰富瑞投资银行：维持PTC Therapeutics(PTCT.US)评级，由买入调整至买入评级, 目标价由35.00美元调整至46.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2437348300","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2437348300?lang=zh_cn&edition=full","pubTime":"2024-05-21 01:45","pubTimestamp":1716227105,"startTime":"0","endTime":"0","summary":"杰富瑞投资银行：维持PTC Therapeutics(PTCT.US)评级，由买入调整至买入评级, 目标价由35.00美元调整至46.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240521014507877f4dba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240521014507877f4dba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PTCT","PTC","LENZ"],"gpt_icon":0},{"id":"2435351932","title":"BUZZ-PTC Therapeutics 在 FDA 授予基因疗法优先审查权后股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2435351932","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2435351932?lang=zh_cn&edition=full","pubTime":"2024-05-14 21:47","pubTimestamp":1715694440,"startTime":"0","endTime":"0","summary":"    5月14日 - ** 制药商 PTC Therapeutics    股价上涨 4.53% 至 33.13 美元** 该公司称，美国食品和药物管理局已接受 ，并授予其用于治疗AADC缺乏症的实验性基因疗法Upstaza优先审查权。** Aromatic l-amino acid decarboxylase 缺乏症是一种罕见的遗传性疾病，其特征是 AADC 活性降低，而 AADC 是一种参与制造多巴胺和血清素等神经递质的酶，负责神经系统中神经元之间的交流。** Upstaza 旨在纠正潜在的基因缺陷，它能将一个正常运作的 DDC 基因直接送入大脑皮质，增加 AADC 酶的数量，恢复多巴胺的分泌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4554","PTC","LU1923623000.USD","BK4023","BUZZ","BK4585","LU0320765992.SGD","LU1951198990.SGD","PTCT","LU0109394709.USD","BK4576","BK4139","BK4588","LENZ","LU1951200564.SGD"],"gpt_icon":0},{"id":"2434895367","title":"Ptc Therapeutics, Inc.盘中异动 下午盘大幅拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434895367","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434895367?lang=zh_cn&edition=full","pubTime":"2024-05-11 03:28","pubTimestamp":1715369291,"startTime":"0","endTime":"0","summary":"北京时间2024年05月11日03时28分，Ptc Therapeutics, Inc.股票出现异动，股价大幅拉升5.06%。Ptc Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。其相关个股中，诺瓦瓦克斯医药、Clene Inc C/Wts 30/12/2025 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Transcode Therapeutics, Inc.、Allarity Therapeutics, Inc.、诺瓦瓦克斯医药较为活跃，换手率分别为210.86%、207.56%、115.05%，振幅较大的相关个股有Clene Inc C/Wts 30/12/2025 、Celularity Inc C/Wts 16/07/2026 、Nls Pharmaceutics Ltd C/Wts 02/02/2026，振幅分别为80.66%、77.01%、76.58%。Ptc Therapeutics, Inc.公司简介：PTC Therapeutics Inc 是一家生物制药公司，专注于口服小分子疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110328127a594606&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405110328127a594606&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","LENZ","LU0109394709.USD","LU0320765992.SGD","PTCT","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ptcbio.com","stockEarnings":[{"period":"1week","weight":0.0327},{"period":"1month","weight":0.0496},{"period":"3month","weight":0.0571},{"period":"6month","weight":0.2595},{"period":"1year","weight":0.6212},{"period":"ytd","weight":0.3295}],"compareEarnings":[{"period":"1week","weight":0.0154},{"period":"1month","weight":0.0165},{"period":"3month","weight":0.0433},{"period":"6month","weight":0.0898},{"period":"1year","weight":0.3385},{"period":"ytd","weight":0.1993}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ptc Therapeutics, Inc.于1998年3月31日注册成立为一家特拉华州公司。 PTC Therapeutics股份有限公司是一家生物制药公司，专注于用于转录后控制过程中的口服药，专有的小分子药物的发现和开发。同时该公司的研发计划针对于多个治疗领域，公司特别专注于孤儿和超孤儿混乱疾病的治疗的开发和商业化。公司主导的候选产品是ataluren，该产品用于治疗过程中所出现的一种被称为无义突变基因突变的遗传性疾病的治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.108578},{"month":2,"riseRate":0.545455,"avgChangeRate":-0.006897},{"month":3,"riseRate":0.454545,"avgChangeRate":-0.072507},{"month":4,"riseRate":0.545455,"avgChangeRate":0.029187},{"month":5,"riseRate":0.545455,"avgChangeRate":0.027228},{"month":6,"riseRate":0.545455,"avgChangeRate":0.056583},{"month":7,"riseRate":0.636364,"avgChangeRate":0.023181},{"month":8,"riseRate":0.75,"avgChangeRate":0.072316},{"month":9,"riseRate":0.5,"avgChangeRate":0.020776},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.105915},{"month":11,"riseRate":0.636364,"avgChangeRate":0.126397},{"month":12,"riseRate":0.636364,"avgChangeRate":0.045178}],"exchange":"NASDAQ","name":"PTC Therapeutics Inc.","nameEN":"PTC Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.0","shortVersion":"4.28.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PTC Therapeutics Inc.(PTCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供PTC Therapeutics Inc.(PTCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"PTC Therapeutics Inc.,PTCT,PTC Therapeutics Inc.股票,PTC Therapeutics Inc.股票老虎,PTC Therapeutics Inc.股票老虎国际,PTC Therapeutics Inc.行情,PTC Therapeutics Inc.股票行情,PTC Therapeutics Inc.股价,PTC Therapeutics Inc.股市,PTC Therapeutics Inc.股票价格,PTC Therapeutics Inc.股票交易,PTC Therapeutics Inc.股票购买,PTC Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PTC Therapeutics Inc.(PTCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供PTC Therapeutics Inc.(PTCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}